MILLIAN OKAFOR: Open Payments
NPI 1114403631 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 55 payments from 14 companies in 2025. Trend: 2023 $572 · 2024 $849 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $307 |
| Otsuka America Pharmaceutical, Inc. | 10 | $256 |
| Vanda Pharmaceuticals Inc. | 8 | $209 |
| Janssen Pharmaceuticals, Inc | 6 | $120 |
| Lundbeck LLC | 3 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| Axsome Therapeutics, Inc. | 2 | $65 |
| Bausch Health US, LLC | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
Products named: REXULTI, VRAYLAR, FANAPT, SPRAVATO, CAPLYTA, Auvelity, APLENZIN, COBENFY.
Industry payments across FL — which companies pay providers there.
